Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
21 April 2021 | Story Financial Aid

Dear Student

Please take note that the NSFAS appeals process is now open.

FIRST TIME AND NEW APPLICANTS

First time1 and new applicants2 for NSFAS funding for 2021 whose applications were rejected by NSFAS must submit their appeal electronically on the MyNSFAS portal. Financial Aid offices may not accept manual forms for this group of students and may not submit manual appeals for this group to NSFAS. You will be able to track your status on the MyNSFAS portal.

SENIOR RETURNING/CONTINUING STUDENTS

Please see appeal form attached.

The following process is ONLY applicable to NSFAS returning/continuing students and exclude first time
and new applicants for NSFAS funding in 2021.

The following documents must be submitted from your “ufs4life” email address for your appeal to be
considered:
  • 1. Completed and signed appeal form attached herewith.
  • 2. Ensure that the relevant box indicating the reason for your appeal is checked.
  • 3. Signed motivation
  • 4. Supporting documents (e.g. Medical certificates, death certificate etc.) Your appeal can
  • unfortunately not be considered in the absence of documentation in support of your reason and
  • motivation for the appeal.
Please note that NSFAS confirmed that you cannot appeal if you exceeded the N+ period. You can only
submit an appeal for one of the reasons provided on the appeal form.

Please submit the abovementioned required documents as one single combined attachment in legible 
PDF format to your campus specific e-mail address below:
Bloemfontein Campus – NSFASAppealsBfn@ufs.ac.za
Qwaqwa Campus – NSFASAppealsQQ@ufs.ac.za
The closing date for submission of appeals is 30 April 2021 at 16:00 and no appeals will be accepted after
this date.

Issued by

Financial Aid

 

News Archive

Counterfeit HIV / AIDS drugs must be dealt with
2006-02-16

Some of the guests attending the lecture were from the left Prof Johan Henning (Dean:  UFS Faculty of Law), Dr Jayasuriya, Prof Voet du Plessis (Head: UFS Department of Mercantile Law) and Dr Ezekiel Moraka (Vice-Rector:  Student Affairs at the UFS).
Photo: Stephen Collett

Counterfeit HIV / AIDS drugs must be dealt with

An international legal expert who has worked with various UN agencies has called on governments to deal quickly and decisively with people dealing in counterfeit HIV / AIDS drugs.

The Vice-President of the Global Jurists Foundation and former head of the UNAIDS secretariat in Pakistan, Dr Dayanath Jayasuriya, was speaking at the University of the Free State in Bloemfontein.

Delivering a guest lecture on HIV/ AIDS and human rights in developing countries, Dr Jayasuriya said counterfeit drugs were spreading at an alarming rate throughout the world.  He said that in particular counterfeit HIV / AIDS drugs contribute to the vulnerability of persons living with HIV / AIDS.

“Only a few countries have integrated anti-counterfeit drug provisions into national legislation on medicinal drugs” he said.
According to Dr Jayasuriya, the violation of the rights of people living with HIV / AIDS is continuing despite the fact that many governments have adopted various charters and declarations that are meant to guarantee the human rights of citizens.

He said these violations have included the brutal murder of persons with HIV / AIDS.

Other violations include verbal abuse and physical injuries through acts of torture; deprivation or denial of access to employment; medical facilities, including drugs; accommodation; food; social service benefits; insurance; custody of children, and so on.

“In recorded human history HIV / AIDS is by no means the first ever major public health epidemic to confront human kind. However, none of the other epidemics generated the same degree and intensity of human rights concerns,” Dr Jayasuriya said.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept